Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies

Rituximab promotes strong immunosuppression leading to a high risk of hepatitis B reactivation (HBV-R) and chronic infection. Current recommendations on HBV-R prevention are expensive and poorly individualized. In resolved hepatitis B patients, previous studies suggest that anti-HBs titers before im...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araujo-Neto, João Marcello, Guimarães, Gabriela Sousa, Fernandes, Flavia Ferreira, Soares, Marcelo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415137/
https://www.ncbi.nlm.nih.gov/pubmed/36016402
http://dx.doi.org/10.3390/v14081780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415137/
https://www.ncbi.nlm.nih.gov/pubmed/36016402
http://dx.doi.org/10.3390/v14081780

Ejemplares similares